Drug intelligence / Profile preview

polycinnamyl alcohol

Development stage: Unknown
Lead developer: Chinese PLA General Hospital
Modality: Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration: Injection

Overview

Polycinnamyl alcohol is an injectable polymer being investigated for the treatment of internal hemorrhoids. Based on its use in a clinical trial alongside or in a similar context to Lauromacrogol (Polidocanol), it is likely a sclerosing agent. Sclerosing agents work by inducing fibrosis and obliteration of the target blood vessels.

Other names: poly cinnamol

Beyond the preview

Go deeper on polycinnamyl alcohol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on polycinnamyl alcohol.

Explore the full profile